The Cooperative Systematic Studies of Rheumatic Diseases (CSSRD) is conducting a longitudinal study to evaluate and follow patients with early undifferentiated connective tissue disease (EUTCD), including Raynaud's phenomenon, and patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) polymyositis or dermatomyositis (PM) and progressive systemic sclerosis (PSS) to determine what historical, physical, or serological features are predictive of the eventual disease process over a five year period. The recruitment goal for this study was 200 patients with EUTCD, and 50 each with RA, SLE, PM and PSS. Sera obtained from patients enrolled in this study and clinical trials previously conducted by the CSSRD are being banked for subsequent analyses.
| Alarcon, G S; Tilley, B C; Li, S et al. (1999) Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA. J Rheumatol 26:1065-7 |
| Dahl, S L; Samuelson, C O; Williams, H J et al. (1990) Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials. Pharmacotherapy 10:79-84 |
| Anderson, J J; Felson, D T; Meenan, R F et al. (1989) Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 32:1093-9 |
| Williams, H J; Ward, J R; Dahl, S L et al. (1988) A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 31:702-13 |
| Lundberg, M S; Cannon, G W; Ward, J R (1988) Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients. Arthritis Rheum 31:909-13 |
